Please join CLiC scientific committee leaders Dr. Carolyn Owen, Dr. Graeme Fraser, and Dr. April Shamy for a webinar Wednesday, May 9, 7:00 pm EST (access info was sent to you by email on April 30) to review the recent online discussion in the CLiC community around the following questions:
- Q1: Would you be willing to change your practice to use VR in first relapse instead of ibrutinib based on the MURANO data? (3 replies to date)
- Q2: In which population should FCR still be considered the standard of care in Canada? (2 repliesto date)
- Q3: Based on currently available data, is chemo-immunotherapy an appropriate option for patients with relapsed CLL or should every patient be treated with targeted therapy at relapse? (1 reply to date)
Webinar connection details were sent to you by email on April 30 – please check your inbox. If you have any questions about the webinar or how to connect, please contact paul.abbass@legitimed.com.
Prior to the webinar, you are invited to visit the CLiC community on Sosido to review the questions & responses and to reply with your personal clinical perspectives
